[{"Assets_0_Q3_USD":2351789000.0,"CommonStockSharesOutstanding_0_Q3_shares":54678000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-283695000.0,"NetIncomeLoss_1_Q3_USD":-145480000.0,"NetIncomeLoss_3_Q3_USD":-406602000.0,"StockholdersEquity_0_Q3_USD":2000790000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":11528000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":35336000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]